Meiwan Chen
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 13
- Advanced biosensing and bioanalysis techniques 12
- Extracellular vesicles in disease 6
-
- Nanoplatforms for cancer theranostics 28
- Co-authors
- Fengfeng Xiao (1 shared paper)Huile Gao (1 shared paper)Shaojun Peng (1 shared paper)Zhangfeng Zhong (3 shared papers)Nana Zhao (4 shared papers)Yitao Wang (6 shared papers)Xiuping Chen (2 shared papers)Yitao Wang (2 shared papers)
- Journals
- Biomaterials Science (8 papers)Advanced Materials (6 papers)Journal of Controlled Release (5 papers)Chinese Medicine (3 papers)ACS Applied Materials & Interfaces (3 papers)
- Partner nations
- MacaoChinaUnited States
In The Last Decade
Meiwan Chen
95 papers receiving 2.7k citations
Meiwan Chen's Hit Papers
Peers
Comparison fields: 5 of 123
- Biomaterials 553
- Pharmaceutical Science 219
- Molecular Medicine 113
- Biomedical Engineering 915
- Pharmacology 171
Countries citing papers authored by Meiwan Chen
This map shows the geographic impact of Meiwan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiwan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiwan Chen more than expected).
Fields of papers citing papers by Meiwan Chen
This network shows the impact of papers produced by Meiwan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiwan Chen. The network helps show where Meiwan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiwan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-cancer natural products isolated from chinese medicinal herbs Hit paper breakdown → | 2011 | 328 |
| 2 | Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy Hit paper breakdown → | 2021 | 310 |
| 3 | 2015 | 99 | |
| 4 | 2014 | 98 | |
| 5 | 2014 | 93 | |
| 6 | 2022 | 92 | |
| 7 | 2021 | 83 | |
| 8 | 2021 | 61 | |
| 9 | 2023 | 57 | |
| 10 | 2017 | 51 | |
| 11 | 2017 | 50 | |
| 12 | 2012 | 44 | |
| 13 | 2022 | 44 | |
| 14 | 2022 | 44 | |
| 15 | 2018 | 40 | |
| 16 | 2022 | 39 | |
| 17 | 2020 | 39 | |
| 18 | 2015 | 37 | |
| 19 | 2021 | 36 | |
| 20 | 2011 | 35 |
About Meiwan Chen
Meiwan Chen is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Materials Chemistry and Pharmaceutical Science, having authored 96 papers that have together received 2.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (28 papers), Nanoparticle-Based Drug Delivery (16 papers), RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (12 papers), Advanced Nanomaterials in Catalysis (10 papers), Extracellular vesicles in disease (6 papers), Advancements in Transdermal Drug Delivery (5 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Biomaterials (553 citations), Pharmaceutical Science (219 citations), Molecular Medicine (113 citations), Biomedical Engineering (915 citations) and Pharmacology (171 citations). Meiwan Chen has collaborated with scholars based in Macao, China and United States. Frequent co-authors include Fengfeng Xiao, Huile Gao, Shaojun Peng, Zhangfeng Zhong, Nana Zhao, Yitao Wang, Xiuping Chen, Yitao Wang, Ka Hong Wong and Shengpeng Wang. Their work appears in journals such as Biomaterials Science, Advanced Materials, Journal of Controlled Release, Chinese Medicine and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.